// App-Quantinova.ai

5083 : Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer.

Researchers

Presenter

  • Sumit Kumar Subudhi

Principal Investigators

  • Glenn Heller

  • Daniel Costin Danila

  • Aseem Anand

  • Kristine Peregrino Lacuna

  • Aliaksandra Samoila

  • Martin Fleisher

  • Howard I. Scher

Medical Centers

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Carboxypeptidase E

  • Circulating tumor cells

  • Prostate specific antigen

  • Colony stimulating factor 1

  • Human albumin

  • Interleukin 1

  • Interleukin 10

  • Interleukin 12

  • Interleukin 13

  • Interleukin 4

  • Interleukin 5

  • Interleukin 6

  • Lactate dehydrogenase

  • Tumor necrosis factor

Drug/Treatment

  • IL-12

  • Interleukin-10

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved